-
Security Type
-
SAFE
-
Categories
-
Other
-
Min Investment
-
$60
-
Location
-
Philadelphia, PA
-
Offering Date
-
April 30, 2019
-
Expected Close Date
-
August 01, 2019
-
Target Raise
-
$50.00K-$1.07M
Company Description
Using smart, at-home blood testing technology to enable personalized medicine
Key Deal Facts
Smart, at-home blood testing device with several disease specific test cartridges
Y Combinator company that has raised $1M from leading Silicon Valley investors
Leadership team of strong technical founders and CEO and CMO with 30+ years of experience and multiple exits of eight- and nine-figures in the diagnostics industry
4 patents and 3 peer-reviewed publications covering the core technology
$400k in contracts with multiple high impact U.S. government agencies and a top 5 global pharma company
Initial focus in the $3B+ cardiac diagnostics market segment with plans to expand into the broader $50B+ lab testing and patient monitoring markets
Use of Proceeds
Campaign marketing expenses, salaries and wages, technology and development
Management Team / Advisory Board Bios
see offering page for details